A ceRNA-Based Multi-Omics Analysis Identifies a Prognostic Signature in Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) remains clinically heterogeneous, and competing endogenous RNA (ceRNA) derived prognostic biomarkers require further characterization. This study integrated TCGA-LUAD RNA-seq, miRNA-seq, survival, mutation, and methylation data to generate a ceRNA network and develop a survival-associated signature. Differential expression analysis identified 4,686 mRNAs, 2,220 lncRNAs, and 264 miRNAs dysregulated between tumor and normal samples. The final ceRNA network contained 9 lncRNAs, 9 miRNAs, 117 mRNAs. Cox and LASSO analyses identified a two-RNA prognostic signature composed of ITGB1-DT and IGF2BP1. High-score patients showed shorter overall survival and the risk score remained independently associated with survival after adjustment for age, gender, and stage. External validation in CPTAC-LUAD supported the model mainly as a continuous prognostic score. The high-risk group showed immunosuppressive and hypoxia-related features, increased tumor mutation burden, higher TP53 mutation frequency, and reduced IGF2BP1 regulatory-region methylation associated with increased IGF2BP1 expression. These findings suggest that the ITGB1-DT and IGF2BP1 signature may serve as a prognostic biomarker for LUAD and provide insight into ceRNA-associated tumor features. Further experimental validation required.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-12
DOI
https://doi.org/10.20944/preprints202611.1350.v1
Primary Topic
Cancer-related molecular mechanisms research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

A ceRNA-Based Multi-Omics Analysis Identifies a Prognostic Signature in Lung Adenocarcinoma

Md. Shariful Islam, Md. Nahian, Abul Kalam Azad, M. A. Khan et al.
Preprints.org
Cancer-related molecular mechanisms research
preprint

A ceRNA-Based Multi-Omics Analysis Identifies a Prognostic Signature in Lung Adenocarcinoma

Md. Shariful Islam, Md. Nahian, Abul Kalam Azad, M. A. Khan, Mohammad Ariful Islam
preprint en

Abstract

Lung adenocarcinoma (LUAD) remains clinically heterogeneous, and competing endogenous RNA (ceRNA) derived prognostic biomarkers require further characterization. This study integrated TCGA-LUAD RNA-seq, miRNA-seq, survival, mutation, and methylation data to generate a ceRNA network and develop a survival-associated signature. Differential expression analysis identified 4,686 mRNAs, 2,220 lncRNAs, and 264 miRNAs dysregulated between tumor and normal samples. The final ceRNA network contained 9 lncRNAs, 9 miRNAs, 117 mRNAs. Cox and LASSO analyses identified a two-RNA prognostic signature composed of ITGB1-DT and IGF2BP1. High-score patients showed shorter overall survival and the risk score remained independently associated with survival after adjustment for age, gender, and stage. External validation in CPTAC-LUAD supported the model mainly as a continuous prognostic score. The high-risk group showed immunosuppressive and hypoxia-related features, increased tumor mutation burden, higher TP53 mutation frequency, and reduced IGF2BP1 regulatory-region methylation associated with increased IGF2BP1 expression. These findings suggest that the ITGB1-DT and IGF2BP1 signature may serve as a prognostic biomarker for LUAD and provide insight into ceRNA-associated tumor features. Further experimental validation required.

Preprints.org
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon